GlassScriptPhysician profile
Chester C Cheng
NPI 1477716223
$2,325.53
in general payments reported to CMS, 2019-2025
17 companies · $427 in 2025
The $427 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $36.64 · 2021: $575 · 2022: $158 · 2023: $404 · 2024: $611 · 2025: $427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,424 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,423.90 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $391.70 | 2023-2025 | Miebo, Xiidra |
| Glaukos Corporation | $287.85 | 2021-2025 | Photrexa Viscous and Photrexa, Kxl System (Not Refurbished) |
| Sight Sciences, INC. | $253.50 | 2021 | |
| Dompe US, INC. | $241.26 | 2024-2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $222.25 | 2021-2022 | |
| Alcon Vision LLC | $136.76 | 2023 | Wavelight Refractive Suite |
| Apellis Pharmaceuticals, INC. | $125.00 | 2024 | Syfovre |
| Kala Pharmaceuticals, INC. | $123.91 | 2021 | |
| Oyster Point Pharma, INC. | $121.92 | 2024 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $116.92 | 2025 | Xdemvy |
| Shire North American Group INC | $113.74 | 2019 | |
| Abbvie INC. | $101.54 | 2024 | |
| Allergan, INC. | $20.51 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $16.03 | 2023 | Trelegy Ellipta |
| Sun Pharmaceutical Industries INC. | $16.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chester Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.